Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by LaserStock29on Jan 11, 2020 8:50am
133 Views
Post# 30541778

RE:Had a contact with IR

RE:Had a contact with IRWhat are our pps catalysts going into the agm?
Oilminerdeluxe wrote:

Ok, so this is only my interpretation of things. I might be wrong, or right, This will take a long time. We better get used to it. There is a difference between a phase I1 and a phase II study. In fact, a phase II is a whole other animal. We got info at 3,6,9,12 and 18 months for the phase 1 trial, if I am not mistaken. This is simply not going to happen in this phase II trial, unless TLT differ from all other companies out there. I was told sometimes shareholders do not get to know results until the whole trial is over! Sure hope we do not have to wait 2-3 years. The company has stated several times that it will report material events if they occur. I think most of us here can agree on that. What are material events? To me, that is either patients getting hurt from the study or stellar results. We hope for the latter since the method seems very, very safe. BUT the company has also mentioned the figure 20-25 people for accelerated approval may times. At this point, we have 2 people at 3 months. No matter how much we want to know, 2 people at 3 months is NOT considered material no matter how healthy they are. We simply need a whole lot more patients for it to matter at all. We have to accept that. 2 people is nothing. And sadly, I think 3 months healthy is  considered nice, but it needs to be longer to matter. Perhaps that means we have to wait until 20-25 have done a full year, or at least half. Until that second treatment. Yes, that means a lot more waiting. That is how things apparently are done and we simply have to accept it. That is unless Theralase changes the way to release updates compared to others. In fact, it is not totally out of the question, but it is something people should not bet money on. I would sleep better if I knew P1+P2 had healthy bodies and are dancing with joy, but that is most likely not going to happen. I now believe (hope I am wrong) that we will not hear anything until they have enough data to do  statistical facts. I have a relative who is a math wizard, like unreal math. Weapon systems and cool stuff, encryption codes and stuff. She told me once that in order to make any kind of statistical statement, you need at least 7 people who get the exact same results, then you can perhaps start to make weak assumptions. So if she is right, we need at least 7 people. I can't remember, but wasn't Sesen 7 people? We have soon treated 7 people, so that is good. But will those 7 people be enough to include in a 3 month update, or will they wait until 6 month or 12 month? Or will the company wait to update until they have reached the 20-25 people they have talked about in the past?

I think it is safe to say, that we can all hope for updates, but we must be prepared to wait a very long time. I think management is well aware that we as shareholders are impatient and that they should perhaps update us on just how they plan to release info in the future so we at least know that. Now I got that e-mail i bit late yesterday so I might have misread it ( I admit I am not the sharpest tool in the box), but to me anyway, i think we will simply have to wait a lot longer than we want. Now every study is different and TLT''s tech is different from all others, that cOULD mean they will report differently than what others do, so we should not assume it will take a year before we hear anything, but I suspect chances are we will not get updates as regular as in phase I.
But for heaven's sake, contact the IR folks and ask if you want to know about it. Perhaps they will heed our desires and give us something. But by not saying anything they are following protocol and the way things are usually done. So don't be mad at them, they are just doing what they are supposed to do. I think we will get handsomely rewarded in the end. If Keytruda had 20% at 12 month, we stand a very, very, very good chance of beating that. I will revist the emaillater today and if I have made a mistake reading it, I will apologize and revise what I wrote above.

It is all down to patience and patients. As it always has been. I hope a lot of people at 3 months will see an update from the company, but I am not counting on it as a 100% certainty. Now off to the gym to impress women half my age.




 



Bullboard Posts